Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants
Clinical trial NCT03550313 · TERMINATED
Trial details
- NCT number
- NCT03550313
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2020-11-05
- Enrollment
- 565
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.